The Epidemiology and Clinical Presentation of Lassa Fever: Information for Medical Providers

Learn to Identify Lassa Fever

While viral hemorrhagic fevers (VHFs), like Lassa fever, are very serious, they are not common in the U.S. However, it is important for healthcare providers to understand high consequence viruses, like Lassa fever, so they can appropriately diagnose and care for their patients. This video, the first in a two-part training series on Lassa fever, provides an overview, describing the epidemiology and clinical presentation of the virus.

What you will learn

By the end of this training, you will be able to:

  • Describe at least two risk factors of Lassa fever.
  • Name at least two countries where Lassa fever is endemic.
  • Describe at least five signs or symptoms of Lassa fever.
  • Describe the implications of Lassa fever infection on pregnant women.
  • Describe the clinical syndrome associated with Lassa fever in children.
  • Describe my role, responsibilities, and scope of practice as a team member when diagnosing Lassa fever.
Instructions for Obtaining Continuing Education (CE)

In order to receive continuing education (CE) for WD4185 – The Epidemiology and Clinical Presentation of Lassa Fever: Information for Medical Providers, please visit TCEO and follow these 9 Simple Steps before February 1, 2023.

  1. Complete the activity.
  2. Complete the evaluation at www.cdc.gov/GetCE.
  3. Pass the posttest at 75 % at www.cdc.gov/GetCE.

FEES: No fees are charged for CDC’s CE activities.

After Registering for the CE Credit Take the Required Pre-test
Training Video—The Epidemiology and Clinical Presentation of Lassa Fever: Information for Medical Providers
Accreditation Statements:
jointly accredited provider mark

In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention designates this activity for 0.2 nursing contact hours.

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.